|
| 临床药师参与制定颅内大动脉狭窄合并房颤的脑梗死患者抗栓治疗策略的实践与分析 |
| Participation of Clinical Pharmacists in Making an Anti Thrombosis Treatment Strategy for an Acute Cerebral Infarction Patient with Atrial Fibrillation and Intracranial Artery Stenosis |
| |
| DOI： |
| 中文关键词: 临床药师 房颤 脑梗死 华法林 |
| 英文关键词:Clinical pharmacist Atrial fibrillation Cerebral infarction Warfarin |
| 基金项目: |
|
| 摘要点击次数: 1272 |
| 全文下载次数: 1426 |
| 中文摘要: |
| 摘 要 目的：探讨临床药师在协助医师制定抗栓治疗策略中的作用。方法：临床药师积极参与颅内大动脉狭窄合并房颤的脑梗死患者抗栓治疗策略的制定，通过对患者进行卒中病因分型、卒中风险评估、以及循证证据的分析，为医师提供了充分的决策依据，并提供合理的药物治疗建议。结果：临床药师协助医师为患者制定出更加合理、个性化的抗栓治疗策略。结论：临床药师参与临床治疗团队，能为医师的药物治疗决策提供积极的帮助。 |
| 英文摘要: |
| ABSTRACT Objective:To investigate the role of clinical pharmacists played in developing an anti thrombosis treatment strategies. Methods:Clinical pharmacist actively participated in making an anti thrombosis treatment strategy for an acute cerebral infarction patient with atrial fibrillation and intracranial artery stenosis. Through the classification of ischemic stroke subtypes according to TOAST criteria, the assesment of stroke risk, and the analysis of evidence-based medicine, clinical pharmacist provided a foudation for doctor’s decision making and offered reasonable suggestions of drug therapy. Results:Clinical pharmacist helped the doctor make a safe and personalized anti thrombosis treatment strategy for the patient. Conclusion: As a member of treament team, clinical pharmacist can offer benificial suggestions and positive helps for doctors’ treatment strategies. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
